Log In

Term Description

Identifies other treatment given at this facility that cannot be defined as surgery, radiation, or systemic therapy according to the defined data items in this manual. Treatment for reportable hematopoietic diseases can be supportive care, observation, or any treatment that does not meet the usual definition in which treatment modifies, controls, removes, or destroys proliferating cancer tissue. Such treatments include phlebotomy, transfusions, and aspirin.

Information on other therapy is used to describe and evaluate the quality-of-care and treatment practices... NAACCR Data Standards and Data Dictionary Version 11

LOINC Names Get Info

Fully-Specified Name
Other Rx:Type:Pt:Cancer.XXX:Nom:
Long Common Name
Other treatment Cancer
Short Name
Other Rx Cancer

Part Model Get Info

  • Component
    Other Rx
    LP73035-5
    • Analyte
      Other Rx
      LP73035-5
      • Component Numerator
        Other Rx
        LP73035-5
        • Component Numerator Core
          Other Rx
          LP73035-5
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Type
    LP6886-8
  • Time
    Pt
    LP6960-1
  • System
    Cancer.XXX
    LP7102-9
    • System Core
      Cancer.XXX
      LP7102-9
    • Super System
      NULL
       
  • Scale
    Nom
    LP7750-5
  • Method
    NULL
     

Normative Answer List: LL99-3

AnswerCodeScoreAnswer ID
No other cancer-directed therapy except as coded elsewhere0LA4558-8
Other cancer-directed therapy1LA4730-3
Other experimental cancer-directed therapy (not included els2LA4726-1
Double-blind study, code not yet broken3LA3962-3
Unproven therapy (including laetrile, krebiozen, etc.)6LA4451-6
Patient or patient's guardian refused therapy which would ha7LA4639-6
Other cancer-directed therapy recommended, unknown if admini8LA4729-5
Unknown if other cancer-directed therapy administered9LA4411-0

Basic Attributes

Class
TUMRRGT
Type
Clinical
First Released
Version 1.0m
Last Updated
Version 2.29 (MIN)

Member of these Panels

LOINCLong Common Name
49083-9North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel
59852-4North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)Άλλη θεραπεία:Type:Pt:Καρκίνος.XXX:Nom:
Synonyms: Nom Pt TUMRRGT Type XXX Άλλη θεραπεία Καρκίνος Καρκίνος.XXX
es-ARSpanish (Argentina)OTHER RX:tipo:punto en el tiempo:cáncer.XXX:Nominal:
es-MXSpanish (Mexico)Otro Rx:Tipo:Punto temporal:Cancer.XXX:Nominal:
it-ITItalian (Italy)Altra terapia:Tipo:Pt:Cancro.XXX:Nom:
Synonyms: Altro trattamento Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori
ru-RURussian (Russian Federation)Другое Rx:Тип:ТчкВрм:Рак.XXX:Ном:
Synonyms: Номинальный;Именной Точка во времени;Момент
zh-CNChinese (China)其他治疗方案:类型:时间点:癌.XXX:名义型:
Synonyms: NAACCR 肿瘤登记;癌症登记中心北美协会肿瘤登记;肿瘤注册;肿瘤登记（NAACCR）;肿瘤登记（癌症登记中心北美协会）;癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR 不明癌;不明癌症;未作说明的癌;未作说明的癌症;癌.不明;癌.未作说明的;癌症.XXX;癌症.不明;癌症.未作说明的;此处未作说明的癌 不明的;其他;将在相应消息内其他部分之中加以详细说明;未作详细说明的;未作说明的;未做说明的标本;未加规定的;未加说明的标本;杂项 其他处方;其他 Rx 其他的 其它 其它的 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 别的 另外的 型 时刻;随机;随意;瞬间 癌

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=21949-3